Display options
Share it on

Scand J Child Adolesc Psychiatr Psychol. 2016 May;4(2):96-104. doi: 10.21307/sjcapp-2016-014.

Behavioral Weight Loss Treatment in Antipsychotic Treated Youth.

Scandinavian journal of child and adolescent psychiatry and psychology

Ginger E Nicol, Rachel P Kolko, Monica Mills, Thrudur Gunnarsdottir, Michael D Yingling, Julia A Schweiger, Eric J Lenze, John W Newcomer, Denise Wilfley

Affiliations

  1. Healthy Mind Lab, Department of Psychiatry, Washington University School of Medicine, St. Louis MO.
  2. Department of Psychiatry, Western Psychiatric Institute, University of Pittsburgh Medical Center, Pittsburgh, PA.
  3. Department of Psychology, University of Akureyri, Iceland.
  4. Weight Management & Eating Disorders Program, Department of Psychiatry, Washington University School of Medicine, St. Louis MO.
  5. Weight Management & Eating Disorders Program, Department of Psychiatry, Washington University School of Medicine, St. Louis MO; Department of Psychology, Washington University School of Medicine, St. Louis, MO; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO; Department of Pediatrics, Washington University School of Medicine, St. Louis MO.

PMID: 27347489 PMCID: PMC4916921 DOI: 10.21307/sjcapp-2016-014

Abstract

BACKGROUND: Antipsychotic-treated youth have increased risk for the development of obesity and type 2 diabetes. Behavioral weight loss treatments show promise in reducing obesity and diabetes risk in antipsychotic treated adults, but have received no study in antipsychotic treated youth.

OBJECTIVE: We describe a rationale for behavioral weight loss interventions in high-weight antipsychotic treated youth, and report behavioral, anthropomorphic, and metabolic findings from a case series of obese antipsychotic-treated adolescents participating in a short-term, family-based behavioral weight loss intervention.

METHODS: We adapted the Traffic Light Plan, a 16-week family-based weight loss intervention that promotes healthy energy balance using the colors of the traffic light to categorize the nutritional value of foods and intensity of physical activity, adapting a social ecological framework to address health behavior change in multiple social contexts. The intervention was administered to three obese adolescents with long-term antipsychotic medication exposure. Efficacy of the intervention was evaluated with a battery of anthropomorphic and metabolic assessments including weight, body mass index percentile, whole body adiposity, liver fat content, and fasting plasma glucose and lipids. Participants and their parents also filled out a treatment satisfaction questionnaire upon study completion.

RESULTS: Two males and 1 female (all aged 14 years) participated. All 3 participants attended all 16 sessions, and experienced beneficial changes in adiposity, fasting lipids and liver fat content associated with weight stabilization or weight loss. Adolescents and their parents all reported a high level of satisfaction with the treatment.

CONCLUSIONS: Family-based behavioral weight loss treatment can be feasibly delivered and is acceptable to antipsychotic-treated youth and their families. Randomized controlled trials are needed to fully evaluate the effectiveness and acceptability of behavioral weight loss interventions in antipsychotic treated youth and their families.

Keywords: Antipsychotic; At-Risk Youth; Pediatric Obesity; Weight Loss Treatment

References

  1. Am J Clin Nutr. 2000 Aug;72(2 Suppl):521S-8S - PubMed
  2. Curr Psychiatry Rep. 2013 May;15(5):355 - PubMed
  3. Am Fam Physician. 2008 Jul 1;78(1):56-63 - PubMed
  4. Health Psychol. 2007 Sep;26(5):521-32 - PubMed
  5. Am J Community Psychol. 2009 Dec;44(3-4):316-26 - PubMed
  6. JAMA Intern Med. 2015 Aug;175(8):1412-3 - PubMed
  7. J Clin Psychiatry. 2007 Mar;68(3):e07 - PubMed
  8. Am J Psychiatry. 2006 Mar;163(3):402-10 - PubMed
  9. JAMA. 2009 Oct 28;302(16):1765-73 - PubMed
  10. JAMA Pediatr. 2013 Jan;167(1):21-6 - PubMed
  11. Adv Data. 2000 Jun 8;(314):1-27 - PubMed
  12. Am J Physiol. 1989 Mar;256(3 Pt 2):R605-11 - PubMed
  13. Prog Brain Res. 2000;126:325-41 - PubMed
  14. J Pediatr Psychol. 2014 Sep;39(8):809-25 - PubMed
  15. Psychiatr Serv. 2015 Apr 1;66(4):404-10 - PubMed
  16. Pediatrics. 2007 Dec;120 Suppl 4:S254-88 - PubMed
  17. Obesity (Silver Spring). 2008 Feb;16(2):318-26 - PubMed
  18. Am J Psychiatry. 2015 Jan;172(1):71-81 - PubMed
  19. J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1137-44 - PubMed
  20. Arch Pediatr Adolesc Med. 2010 Apr;164(4):344-51 - PubMed
  21. Neuropsychopharmacology. 2003 Mar;28(3):519-26 - PubMed
  22. J Clin Psychiatry. 2007;68 Suppl 4:8-13 - PubMed
  23. J Pediatr. 2013 Mar;162(3):496-500.e1 - PubMed
  24. J Child Adolesc Psychopharmacol. 2009 Oct;19(5):563-73 - PubMed
  25. J Clin Psychopharmacol. 2012 Aug;32(4):458-64 - PubMed
  26. Pediatrics. 2007 Dec;120 Suppl 4:S164-92 - PubMed
  27. Circulation. 2013 Oct 8;128(15):1689-712 - PubMed
  28. Health Psychol. 2007 Jul;26(4):381-91 - PubMed
  29. Early Interv Psychiatry. 2012 Aug;6(3):347-53 - PubMed
  30. Health Psychol. 2004 Jul;23(4):371-80 - PubMed
  31. Exp Neurol. 2008 Jan;209(1):261-7 - PubMed
  32. N Engl J Med. 2013 Apr 25;368(17):1594-602 - PubMed
  33. Brain Res. 1988 Feb 16;441(1-2):403-7 - PubMed
  34. JAMA. 2007 Oct 10;298(14):1661-73 - PubMed
  35. Arch Pediatr Adolesc Med. 2000 Mar;154(3):220-6 - PubMed
  36. Pediatr Clin North Am. 2011 Dec;58(6):1403-24, x - PubMed
  37. Child Adolesc Psychiatry Ment Health. 2013 Aug 15;7(1):31 - PubMed
  38. J Pharmacol Exp Ther. 2000 Oct;295(1):226-32 - PubMed
  39. J Dev Behav Pediatr. 2008 Aug;29(4):276-84 - PubMed
  40. Am J Psychiatry. 2005 Jul;162(7):1361-9 - PubMed
  41. JAMA Psychiatry. 2015 Sep;72(9):867-74 - PubMed
  42. JAMA Psychiatry. 2013 Oct;70(10):1067-75 - PubMed
  43. J Consult Clin Psychol. 2014 Dec;82(6):1140-50 - PubMed

Publication Types

Grant support